For IPO Boutique's "scale of 1 to 5" BUY rating on NewLink Genetics, and our comprehensive analysis, click "Buy Market Research".
NewLink Genetics Quote & Chart - Click for current quote - NLNK
About NewLink Genetics (adapted from NewLink Genetics prospectus): They are a biopharmaceutical company focused on discovering, developing and commercializing novel immunotherapeutic products to improve cancer treatment options for patients and physicians.
This description is adapted from NewLink prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as NewLink "NLNK" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
Used our Comprehensive Single Promo Advisory and want more?
